464 2SMALL (NCT04253145) phase I part: lurbinectidine (LUR) in combination with atezolizumab (ATZ) for second line extensive stage small cell lung cancer (ES-SCLC) patients (pts)

• Luis Paz-Ares,
• Santiago Ponce Aix,
• Alejandro Navarro,
• Reyes Bernabe,
• Maria Eugenia Olmedo,
• Trigo Jose Manuel,
• Jon Zugazagoitia Fraile

Affiliations

Luis Paz-Ares

H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (imas12) / Spanish National Cancer Research Center (CNIO), Madrid, Spain

Santiago Ponce Aix

2Medical Oncology, Sevilla, Spain

Alejandro Navarro

2Hospital Univeristari Vall d’Hebron, Barcelona, Spain

Reyes Bernabe

3Hospital Universitario Virgen del Rocio, Seville, Spain

Maria Eugenia Olmedo

4Hospital Universitario Ramon y Cajal, Madrid, Spain

Trigo Jose Manuel

5Hospital U. Virgen de la Victoria, Malaga, Spain

Jon Zugazagoitia Fraile

1Hospital Universitario 12 de Octubre, Madrid, Spain